Kobe, Japan

Akio Yamada

This inventor holds 4 USPTO granted patents and 1 EPO patent. Top assignees: Eisai R&d Management Co., Ltd., Yamada Machinery Industrial Co., Ltd.. Active years: 1989-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Akio Yamada. Retrieved from https://idiyas.com/inventor/akio-yamada-ekyuowbw

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0


Average Co-Inventor Count = 4.2

ph-index = 1

Forward Citations = 28(Granted Patents)


Company Filing History:


Years Active: 1989-2021

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Akio Yamada: Innovator in Antibody Development

Introduction

Akio Yamada is a prominent inventor based in Kobe, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of antibodies. With a total of 4 patents to his name, Yamada's work has the potential to impact therapeutic approaches in various medical conditions.

Latest Patents

Yamada's latest patents focus on the Anti-EphA4 antibody. This innovative antibody is designed to bind to EphA4 and enhance its cleavage. The patent details a pharmaceutical composition that includes this antibody as the active ingredient. A mouse anti-EphA4 antibody was developed, which exhibits a strong binding affinity towards EphA4. The sequence of the complementarity-determining region (CDR) of this mouse antibody was identified, leading to the production of a humanized version of the antibody for further applications.

Career Highlights

Throughout his career, Akio Yamada has worked with notable companies such as Eisai R&D Management Co., Ltd. and Yamada Machinery Industrial Co., Ltd. His experience in these organizations has contributed to his expertise in research and development within the biotechnology sector.

Collaborations

Yamada has collaborated with esteemed colleagues, including Toshio Imai and Eiji Inoue. These partnerships have likely fostered innovation and advancement in his research endeavors.

Conclusion

Akio Yamada's contributions to antibody development, particularly the Anti-EphA4 antibody, showcase his innovative spirit and dedication to advancing medical science. His work continues to pave the way for new therapeutic options in the field of biotechnology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…